CN1871362A - 卵巢癌的诊断标记物 - Google Patents
卵巢癌的诊断标记物 Download PDFInfo
- Publication number
- CN1871362A CN1871362A CNA200480030838XA CN200480030838A CN1871362A CN 1871362 A CN1871362 A CN 1871362A CN A200480030838X A CNA200480030838X A CN A200480030838XA CN 200480030838 A CN200480030838 A CN 200480030838A CN 1871362 A CN1871362 A CN 1871362A
- Authority
- CN
- China
- Prior art keywords
- haptoglobin
- ovarian cancer
- precursor
- serum
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003904844 | 2003-09-05 | ||
| AU2003904844A AU2003904844A0 (en) | 2003-09-05 | Diagnostic marker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1871362A true CN1871362A (zh) | 2006-11-29 |
Family
ID=34230078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA200480030838XA Pending CN1871362A (zh) | 2003-09-05 | 2004-09-06 | 卵巢癌的诊断标记物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070053896A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1668149A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007504463A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1871362A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2537955A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005024054A1 (cg-RX-API-DMAC7.html) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102686612A (zh) * | 2009-09-29 | 2012-09-19 | 赛托盖德公司 | 靶向cd163受体的偶联物 |
| CN104225619A (zh) * | 2013-06-09 | 2014-12-24 | 上海金鉴生物科技有限公司 | 人ilk基因治疗肿瘤的用途及其相关药物 |
| CN106520924A (zh) * | 2016-10-14 | 2017-03-22 | 浙江大学 | 一种用于检测卵巢癌的引物组及检测方法 |
| CN106544421A (zh) * | 2016-10-21 | 2017-03-29 | 武汉科技大学 | Spag6基因作为卵巢肿瘤诊断和治疗标志物的用途 |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0307428D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
| US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
| GB0307403D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
| US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
| US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
| CN101243319B (zh) * | 2005-06-22 | 2016-01-06 | 约翰·霍普金斯大学 | 卵巢癌的生物标记:ctap3-相关蛋白质 |
| US8249814B2 (en) | 2005-10-21 | 2012-08-21 | Genenews Inc. | Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject |
| WO2007081385A2 (en) | 2006-01-11 | 2007-07-19 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| JP2009524438A (ja) * | 2006-01-27 | 2009-07-02 | トライパス イメージング インコーポレイテッド | 卵巣癌を有する可能性の高い患者を同定するための方法およびそのための組成物 |
| WO2007133710A2 (en) | 2006-05-11 | 2007-11-22 | Raindance Technologies, Inc. | Microfluidic devices and methods of use thereof |
| US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
| US9012390B2 (en) | 2006-08-07 | 2015-04-21 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
| SG140505A1 (en) * | 2006-09-05 | 2008-03-28 | Univ Singapore | Diagnostic biomolecule(s) |
| WO2008097559A2 (en) | 2007-02-06 | 2008-08-14 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| WO2008130623A1 (en) | 2007-04-19 | 2008-10-30 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| EP4047367A1 (en) | 2008-07-18 | 2022-08-24 | Bio-Rad Laboratories, Inc. | Method for detecting target analytes with droplet libraries |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| JP5422785B2 (ja) * | 2008-09-12 | 2014-02-19 | 国立大学法人名古屋大学 | 質量分析法を利用した複数癌腫の血液検出のための方法および生物マーカー |
| WO2010111231A1 (en) | 2009-03-23 | 2010-09-30 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
| US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
| EP2517025B1 (en) | 2009-12-23 | 2019-11-27 | Bio-Rad Laboratories, Inc. | Methods for reducing the exchange of molecules between droplets |
| EP4435111A1 (en) | 2010-02-12 | 2024-09-25 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
| US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
| WO2011143292A1 (en) * | 2010-05-11 | 2011-11-17 | Ohio University | Biomarkers for detecting erythropoietin use in human subjects |
| KR101313184B1 (ko) * | 2010-06-24 | 2013-09-30 | 한국표준과학연구원 | 질병 지표 검출 키트 및 질병 지표 검출 방법 |
| WO2012045012A2 (en) | 2010-09-30 | 2012-04-05 | Raindance Technologies, Inc. | Sandwich assays in droplets |
| EP3859011A1 (en) | 2011-02-11 | 2021-08-04 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
| WO2012112804A1 (en) | 2011-02-18 | 2012-08-23 | Raindance Technoligies, Inc. | Compositions and methods for molecular labeling |
| EP2714970B1 (en) | 2011-06-02 | 2017-04-19 | Raindance Technologies, Inc. | Enzyme quantification |
| US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
| WO2012174569A2 (en) * | 2011-06-17 | 2012-12-20 | The Board Of Trustees Of The University Of Arkansas | New markers for early diagnosis of ovarian cancer, monitoring during therapy, and new therapy options during and after chematherapy |
| US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
| US20130210659A1 (en) | 2012-02-10 | 2013-08-15 | Andrew Watson | Molecular diagnostic screening assay |
| WO2013165748A1 (en) | 2012-04-30 | 2013-11-07 | Raindance Technologies, Inc | Digital analyte analysis |
| EP2986762B1 (en) | 2013-04-19 | 2019-11-06 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| WO2015103367A1 (en) | 2013-12-31 | 2015-07-09 | Raindance Technologies, Inc. | System and method for detection of rna species |
| KR101582416B1 (ko) * | 2014-06-30 | 2016-01-06 | 가톨릭대학교 산학협력단 | 프로합토글로빈을 이용한 간암 진단방법 |
| US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
| CN108884457A (zh) * | 2016-03-29 | 2018-11-23 | 协和发酵麒麟株式会社 | 以在血中与触珠蛋白结合而形成多价免疫复合物的抗体作为有效成分的自身免疫性疾病治疗剂 |
| US10998178B2 (en) | 2017-08-28 | 2021-05-04 | Purdue Research Foundation | Systems and methods for sample analysis using swabs |
| CN114324557B (zh) * | 2021-12-03 | 2024-05-10 | 融智生物科技(青岛)有限公司 | 一种基于MALDI-TOF MS的ζ-珠蛋白的检测方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946774A (en) * | 1987-11-09 | 1990-08-07 | Trustees Of Boston University | Process for detecting cancer and for monitoring the effectiveness of cancer therapy |
| EP0454782B1 (en) * | 1989-01-17 | 1997-04-16 | The Johns Hopkins University | Cancer related haptoglobin (hpr) |
| GB9805477D0 (en) * | 1998-03-13 | 1998-05-13 | Oxford Glycosciences Limited | Methods and compositions for diagnosis of rheumatoid arthritis |
| US7112408B2 (en) * | 2001-06-08 | 2006-09-26 | The Brigham And Women's Hospital, Inc. | Detection of ovarian cancer based upon alpha-haptoglobin levels |
| AU2002335963A1 (en) * | 2001-11-23 | 2003-06-10 | Syn.X Pharma, Inc. | Protein biopolymer markers predictive of alzheimers disease |
| AU2003235749A1 (en) * | 2002-01-07 | 2003-07-24 | John Hopkins University | Biomarkers for detecting ovarian cancer |
-
2004
- 2004-09-06 JP JP2006525571A patent/JP2007504463A/ja active Pending
- 2004-09-06 US US10/570,751 patent/US20070053896A1/en not_active Abandoned
- 2004-09-06 WO PCT/AU2004/001205 patent/WO2005024054A1/en not_active Ceased
- 2004-09-06 CN CNA200480030838XA patent/CN1871362A/zh active Pending
- 2004-09-06 CA CA002537955A patent/CA2537955A1/en not_active Abandoned
- 2004-09-06 EP EP04761242A patent/EP1668149A4/en not_active Withdrawn
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102686612A (zh) * | 2009-09-29 | 2012-09-19 | 赛托盖德公司 | 靶向cd163受体的偶联物 |
| CN102686612B (zh) * | 2009-09-29 | 2019-01-01 | 艾芬尼康有限公司 | 靶向cd163受体的偶联物 |
| CN104225619A (zh) * | 2013-06-09 | 2014-12-24 | 上海金鉴生物科技有限公司 | 人ilk基因治疗肿瘤的用途及其相关药物 |
| CN106520924A (zh) * | 2016-10-14 | 2017-03-22 | 浙江大学 | 一种用于检测卵巢癌的引物组及检测方法 |
| CN106544421A (zh) * | 2016-10-21 | 2017-03-29 | 武汉科技大学 | Spag6基因作为卵巢肿瘤诊断和治疗标志物的用途 |
| CN106544421B (zh) * | 2016-10-21 | 2020-05-08 | 武汉科技大学 | Spag6基因作为卵巢肿瘤诊断和治疗标志物的用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1668149A4 (en) | 2007-01-03 |
| EP1668149A1 (en) | 2006-06-14 |
| US20070053896A1 (en) | 2007-03-08 |
| JP2007504463A (ja) | 2007-03-01 |
| CA2537955A1 (en) | 2005-03-17 |
| WO2005024054A1 (en) | 2005-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070053896A1 (en) | Diagnostic marker for ovarian cancer | |
| Ahmed et al. | Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer | |
| KR100846354B1 (ko) | 혈청 당단백질부터 분리한 폐암 진단용 마커 | |
| US10345309B2 (en) | Biomarkers for gastric cancer and uses thereof | |
| Yang et al. | Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases | |
| CN103547923B (zh) | 乳腺癌的生物标记 | |
| WO2011035433A1 (en) | Selected strains on serum-free growth media for proteomics analysis of lung cancer biomarkers | |
| EP2369349A2 (en) | Non-invasive in vitro method to detect transitional cell carcinoma of the bladder | |
| AU2006304605A1 (en) | Tissue-and serum-derived glycoproteins and methods of their use | |
| AU2015360694A1 (en) | Use of markers including filamin a in the diagnosis and treatment of prostate cancer | |
| WO2010015659A1 (en) | Cancer markers and methods for their detection | |
| US8642347B2 (en) | Urinary CA125 peptides as biomarkers of ovarian cancer | |
| JP4515099B2 (ja) | Lasp−1免疫反応性の決定によって炎症性疾患および感染を診断するための方法 | |
| ES2896056T3 (es) | PD-ECGF como biomarcador de cáncer | |
| CA3214833A1 (en) | Protein markers for the prognosis of breast cancer progression | |
| US20080108549A1 (en) | Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia | |
| AU2004270759A1 (en) | Diagnostic marker for ovarian cancer | |
| KR20160113418A (ko) | 자궁내막증 진단용 조성물 및 이를 포함하는 진단키트 | |
| WO2005003768A1 (en) | Protein markers for human benign prostatic hyperplasia (bph) | |
| WO2010145000A1 (en) | Biomarker of sarcomas | |
| WO2004005536A1 (en) | Nephrotoxicity marker fumarylacetoacetase | |
| HK1206414B (en) | Biomarkers for gastric cancer and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |